These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26153297)

  • 1. Interaction of Fibrin with the Very Low Density Lipoprotein Receptor: Further Characterization and Localization of the Fibrin-Binding Site.
    Yakovlev S; Medved L
    Biochemistry; 2015 Aug; 54(30):4751-61. PubMed ID: 26153297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Fibrin with the Very Low-Density Lipoprotein (VLDL) Receptor: Further Characterization and Localization of the VLDL Receptor-Binding Site in Fibrin βN-Domains.
    Yakovlev S; Medved L
    Biochemistry; 2017 May; 56(19):2518-2528. PubMed ID: 28437098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis for the Interaction of Fibrin with the Very Low-Density Lipoprotein Receptor Revealed by NMR and Site-Directed Mutagenesis.
    Gruschus JM; Yakovlev S; Banerjee K; Medved L; Tjandra N
    Biochemistry; 2021 Aug; 60(33):2537-2548. PubMed ID: 34351135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of VLDLR as a novel endothelial cell receptor for fibrin that modulates fibrin-dependent transendothelial migration of leukocytes.
    Yakovlev S; Mikhailenko I; Cao C; Zhang L; Strickland DK; Medved L
    Blood; 2012 Jan; 119(2):637-44. PubMed ID: 22096238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual functions of the fibrin βN-domains in the VLDL receptor-dependent pathway of transendothelial migration of leukocytes.
    Yakovlev S; Medved L
    Thromb Res; 2022 Jun; 214():1-7. PubMed ID: 35421681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin-VLDL Receptor-Dependent Pathway Promotes Leukocyte Transmigration by Inhibiting Src Kinase Fyn and is a Target for Fibrin β15-42 Peptide.
    Yakovlev S; Cao C; Galisteo R; Zhang L; Strickland DK; Medved L
    Thromb Haemost; 2019 Nov; 119(11):1816-1826. PubMed ID: 31466086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-VLDL receptor monoclonal antibodies inhibit fibrin-VLDL receptor interaction and reduce fibrin-dependent leukocyte transmigration.
    Yakovlev S; Belkin AM; Chen L; Cao C; Zhang L; Strickland DK; Medved L
    Thromb Haemost; 2016 Nov; 116(6):1122-1130. PubMed ID: 27580629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Magnetic Resonance Solution Structure of the Recombinant Fragment Containing Three Fibrin-Binding Cysteine-Rich Domains of the Very Low Density Lipoprotein Receptor.
    Banerjee K; Yakovlev S; Gruschus JM; Medved L; Tjandra N
    Biochemistry; 2018 Jul; 57(30):4395-4403. PubMed ID: 29965730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: localization of the fibrin-binding site within the third extracellular VE-cadherin domain.
    Yakovlev S; Medved L
    Biochemistry; 2009 Jun; 48(23):5171-9. PubMed ID: 19413351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of fibrin with VE-cadherin and anti-inflammatory effect of fibrin-derived fragments.
    Yakovlev S; Gao Y; Cao C; Chen L; Strickland DK; Zhang L; Medved L
    J Thromb Haemost; 2011 Sep; 9(9):1847-55. PubMed ID: 21752185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of fibrin(ogen) with heparin: further characterization and localization of the heparin-binding site.
    Yakovlev S; Gorlatov S; Ingham K; Medved L
    Biochemistry; 2003 Jul; 42(25):7709-16. PubMed ID: 12820880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fibrinogen, fibrin, and fibrin degradation products on transendothelial migration of leukocytes.
    Yakovlev S; Medved L
    Thromb Res; 2018 Feb; 162():93-100. PubMed ID: 29175090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains.
    Gorlatov S; Medved L
    Biochemistry; 2002 Mar; 41(12):4107-16. PubMed ID: 11900554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding sites for the very low density lipoprotein receptor and low-density lipoprotein receptor-related protein are shared within coagulation factor VIII.
    Ananyeva NM; Makogonenko YM; Kouiavskaia DV; Ruiz J; Limburg V; Meijer AB; Khrenov AV; Shima M; Strickland DK; Saenko EL
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):166-77. PubMed ID: 18277139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Neural (N)-Cadherin as a Novel Endothelial Cell Receptor for Fibrin and Localization of the Complementary Binding Sites.
    Yakovlev S; Tjandra N; Strickland DD; Medved L
    Biochemistry; 2024 Jan; 63(2):202-211. PubMed ID: 38156948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site.
    Makogonenko E; Tsurupa G; Ingham K; Medved L
    Biochemistry; 2002 Jun; 41(25):7907-13. PubMed ID: 12069579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the fibronectin COOH-terminal Fib-2 regions with fibrin: further characterization and localization of the Fib-2-binding sites.
    Makogonenko E; Ingham KC; Medved L
    Biochemistry; 2007 May; 46(18):5418-26. PubMed ID: 17425334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of fibrin(ogen) with apolipoprotein(a): further characterization and identification of a novel lysine-dependent apolipoprotein(a)-binding site within the gamma chain 287-411 region.
    Tsurupa G; Yakovlev S; Pechik I; Lamanuzzi LB; Anglés-Cano E; Medved L
    Biochemistry; 2006 Sep; 45(35):10624-32. PubMed ID: 16939214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NH2-terminal fibrin-binding site of fibronectin is formed by interacting fourth and fifth finger domains. Studies with recombinant finger fragments expressed in Escherichia coli.
    Matsuka YV; Medved LV; Brew SA; Ingham KC
    J Biol Chem; 1994 Apr; 269(13):9539-46. PubMed ID: 8144540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.